BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11911255)

  • 1. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.
    Abou-Issa H; Curley RW; Alshafie GA; Weiss KL; Clagett-Dame M; Chapman JS; Mershon SM
    Anticancer Res; 2001; 21(6A):3839-44. PubMed ID: 11911255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model.
    Abou-Issa H; Curley RW; Panigot MJ; Tanagho SN; Sidhu BS; Alshafie GA
    Anticancer Res; 1997; 17(5A):3335-9. PubMed ID: 9413168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.
    Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V
    Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo use of N-(4-hydroxyphenyl retinamide)-0-glucuronide as a breast cancer chemopreventive agent.
    Abou-Issa H; Curley RW; Panigot MJ; Wilcox KA; Webb TE
    Anticancer Res; 1993; 13(5A):1431-6. PubMed ID: 8239515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.
    Alshafie GA; Harris RE; Robertson FM; Parrett ML; Ross M; Abou-Issa H
    Anticancer Res; 1999; 19(4B):3031-6. PubMed ID: 10652588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor.
    Anding AL; Chapman JS; Barnett DW; Curley RW; Clagett-Dame M
    Cancer Res; 2007 Jul; 67(13):6270-7. PubMed ID: 17616685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive activities of C-glucuronide/glycoside analogs of retinoid-O-glucuronides against breast cancer development and growth.
    Curley RW; Abou-Issa H; Panigot MJ; Repa JJ; Clagett-Dame M; Alshafie G
    Anticancer Res; 1996; 16(2):757-63. PubMed ID: 8687125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronide.
    Alshafie GA; Walker JR; Curley RW; Clagett-Dame M; Highland MA; Nieves NJ; Stonerock LA; Abou-Issa H
    Anticancer Res; 2005; 25(3c):2391-8. PubMed ID: 16082771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies.
    Weiss KL; Alshafie G; Chapman JS; Mershon SM; Abou-Issa H; Clagett-Dame M; Curley RW
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1583-6. PubMed ID: 11412986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis.
    Abou-Issa H; Moeschberger M; el-Masry W; Tejwani S; Curley RW; Webb TE
    Anticancer Res; 1995; 15(3):805-10. PubMed ID: 7645962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
    McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
    Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis.
    Chapman JS; Weiss KL; Curley RW; Highland MA; Clagett-Dame M
    Arch Biochem Biophys; 2003 Nov; 419(2):234-43. PubMed ID: 14592467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
    Lewis KC; Hochadel JF
    Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
    Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms.
    Parrett ML; Abou-Issa HM; Alshafie G; Ross MS; Harris RE; Robertson FM
    Anticancer Res; 1999; 19(6B):5079-85. PubMed ID: 10697514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
    Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
    Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin and retinyl acetate as chemopreventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats.
    Ahlersová E; Ahlers I; Kubatka P; Bojková B; Môciková K; Gajdosová S; Onderková HM
    Folia Biol (Praha); 2000; 46(2):69-72. PubMed ID: 10813093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(4-hydroxyphenyl)all-trans-retinamide (4-HPR) high dose effect on DMBA-induced hamster oral cancer: a histomorphometric evaluation.
    Lajolo C; Giuliani M; Sgambato A; Majorano E; Lucchese A; Capodiferro S; Favia G
    Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1133-40. PubMed ID: 18657950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
    Abou-Issa H; Webb TE; Minton JP; Moeschberger M
    J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.